CAMBRIDGE, Mass.--Spotfire announced that Merck has licensed its new-leads discovery system for distribution worldwide across all Merck research sites. The system, which features Spotfire Pro and Spotfire Structure Visualizer, will help Merck biologists and chemists engaged in drug discovery to identify promising drug candidates by enabling them to access and analyze information about relationships between chemical structure and biological activity.